EVEREST MED.LTD DL-0001 (F:6HN) — Stock Price
EVEREST MED.LTD DL-0001 (F:6HN) is currently trading at €2.84 EUR, up 5.19% today. Over the past 52 weeks, shares have ranged between €2.48 and €7.90. This page tracks EVEREST MED.LTD DL-0001's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see EVEREST MED.LTD DL-0001 stock valuation.
EVEREST MED.LTD DL-0001 (6HN) Stock Price Chart — Daily History & Trading Volume
The chart below tracks EVEREST MED.LTD DL-0001's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.
EVEREST MED.LTD DL-0001 Income Statement — Revenue, Profit & Earnings by Year
EVEREST MED.LTD DL-0001's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | €1.71 Billion | €706.68 Million | €125.93 Million | €12.79 Million | €54.00K |
| Cost of Revenue | €524.77 Million | €179.79 Million | €34.41 Million | €4.64 Million | €23.00K |
| Gross Profit | €1.18 Billion | €526.88 Million | €91.52 Million | €8.15 Million | €31.00K |
| Research & Development | €511.04 Million | €528.03 Million | €540.05 Million | €809.74 Million | €613.43 Million |
| SG&A | €1.06 Billion | €758.15 Million | €396.57 Million | €603.23 Million | €440.83 Million |
| Total Operating Expenses | €2.08 Billion | €1.45 Billion | €957.87 Million | €1.41 Billion | €1.05 Billion |
| Operating Income | €-370.67 Million | €-743.90 Million | €-831.93 Million | €-1.40 Billion | €-1.05 Billion |
| EBITDA | — | — | — | — | — |
| EBIT | — | — | — | — | — |
| Interest Expense | €23.27 Million | €22.19 Million | €23.06 Million | €5.59 Million | €4.82 Million |
| Income Before Tax | €-598.36 Million | €-1.04 Billion | €-844.46 Million | €-247.28 Million | €-1.01 Billion |
| Income Tax Expense | — | — | — | — | — |
| Net Income | €-297.77 Million | €-1.04 Billion | €-844.46 Million | €-247.28 Million | €-1.01 Billion |
EVEREST MED.LTD DL-0001 Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes EVEREST MED.LTD DL-0001's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | €6.83 Billion | €4.96 Billion | €5.77 Billion | €6.61 Billion | €6.65 Billion |
| Total Current Assets | €3.37 Billion | €2.02 Billion | €2.51 Billion | €3.41 Billion | €2.69 Billion |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | €887.09 Million | €718.84 Million | €1.83 Billion | €1.16 Billion | — |
| Net Receivables | €500.02 Million | €363.57 Million | €49.86 Million | €5.21 Million | €49.00K |
| Inventory | €32.22 Million | €14.08 Million | €18.94 Million | €11.64 Million | €447.00K |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | — | — | — | — | — |
| Total Liabilities | €1.53 Billion | €886.05 Million | €804.10 Million | €960.25 Million | €753.83 Million |
| Total Current Liabilities | €689.61 Million | €793.54 Million | €328.74 Million | €900.95 Million | €270.27 Million |
| Long-term Debt | €792.12 Million | €55.85 Million | €429.31 Million | €0.00 | €360.93 Million |
| Net Debt | — | — | — | — | — |
| Total Stockholder Equity | €5.30 Billion | €4.07 Billion | €4.97 Billion | €5.65 Billion | €5.89 Billion |
| Retained Earnings | €-10.55 Billion | €-10.06 Billion | €-9.02 Billion | €-8.17 Billion | €-7.92 Billion |
EVEREST MED.LTD DL-0001 Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how EVEREST MED.LTD DL-0001 generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | €-92.56 Million | €-679.51 Million | €-769.19 Million | €-1.16 Billion | €-729.94 Million |
| Capital Expenditures | €348.34 Million | €204.15 Million | €265.95 Million | €432.74 Million | €975.82 Million |
| Free Cash Flow | €-440.90 Million | €-883.66 Million | €-1.04 Billion | €-1.59 Billion | €-1.71 Billion |
| Investing Cash Flow | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | €131.78 Million | €91.10 Million | €73.42 Million | €206.50 Million | €224.98 Million |
| Depreciation | €156.52 Million | €133.62 Million | €76.78 Million | €42.77 Million | €31.12 Million |
| Change in Cash | €987.43 Million | €332.68 Million | €-6.59 Million | €-2.15 Billion | €-1.84 Billion |
EVEREST MED.LTD DL-0001 Earnings History — EPS Actual vs. Analyst Estimates
Track EVEREST MED.LTD DL-0001's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Aug 25, 2026 | — | — | — |
| Mar 25, 2026 | — | — | — |
| Aug 28, 2025 | — | — | — |
| Mar 25, 2025 | — | — | — |